Single-arm multicenter Phase II trial to investigate the efficacy of Botensilimab and Balstilimab in combination with gemcitabine/cisplatin for previously untreated patients with advanced or metastatic biliary tract cancer

(CORAL-1, AIO HB XXXX) (BAlstilimab boTensilimab in the TreAtment of choLangIOcellular carcinoma)

Status: In Vorbereitung

Klinische Settings

Beteiligte

Identifier

Kontakt